Concepedia

Publication | Open Access

Weekly and Monthly Subcutaneous Buprenorphine Depot Formulations vs Daily Sublingual Buprenorphine With Naloxone for Treatment of Opioid Use Disorder

DOIFull Paper Access

232

Citations

40

References

2018

Year

Michelle R. Lofwall, Sharon Walsh, Edward V. Nunes, Genie L. Bailey, Stacey C. Sigmon, Kyle M. Kampman, Michael Frost, Fredrik Tiberg, Margareta Linden, Behshad Sheldon,
JAMA Internal Medicine

Abstract

ClinicalTrials.gov Identifier: NCT02651584.

References

YearCitations

Page 1